Sign in

CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980373793
Phone
973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Chief Medical Officer acquired 40,000 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 72,000 shares (grant or award)
  6. 4 Grant or award President acquired 62,215 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 49,450 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Option exercise Chief Financial Officer acquired 7,857 shares (option exercise)
  10. 4 Open-market sale Director sold 8,000 shares at $8.00 ($64,000)
  11. 4 Option exercise Director acquired 4,000 shares (option exercise)
  12. 4 Option exercise Chief Financial Officer acquired 10,000 shares (option exercise)
  13. 4 Option exercise President and COO acquired 10,123 shares (option exercise)
  14. 4 Option exercise Chief Executive Officer acquired 14,100 shares (option exercise)
  15. 4 Grant or award Chief Medical Officer acquired 140,000 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Operating Officer sold 10,000 shares at $10.00 ($100,000)
  18. 4 Open-market sale Chief Operating Officer sold 4,677 shares at $6.00 ($28,062)
  19. 4 Grant or award Chief Operating Officer acquired 54,100 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 6 of 20 · 395 filings